Monthly Fund Commentary - Aug 2017


Global Titans Fund commentary

Global stocks finished up just over 1% for the month on the back of investor optimism over improving world economic growth. Economic growth accelerated in the US and appears to be broadening across the euro zone. This has raised questions about the direction of monetary policy, however, markets seem relatively unconcerned.

The Fund’s unit price increased by 1.0%, after the cost of protection, in August. The performance was driven by positive contributions from our holdings in PayPal, Visa, Microsoft, Diageo and Unilever. The main negative contributors were Stryker Corp, Reckitt Benckiser, Medtronic, Walt Disney Co and Priceline.com Inc.

The Fund continues to have no foreign currency hedging in place as Insync consider the main risks to the Australian dollar to be on the downside. Over 50% of the Fund is currently protected using our put protection strategy.

The major new buys during the month were Stryker and Accenture. Stryker is a leading global medical technology company that offers a diverse portfolio of reconstructive joint, spine, medical, surgical and neurovascular products. We believe the company is particularly well positioned for the growth in robotically assisted orthopaedic surgery. Accenture is a global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. It is a major beneficiary of the global megatrend in digitisation.

Our only outright sell during the month was Nestle based on valuation. We have held the stock since the inception of the fund.

Oracle - Benefitting from the cloud and artificial intelligence megatrend

Oracle’s products are often mission-critical to the operations of its 400,000 customers, which include some of the largest companies and governments in the world. Oracle’s comprehensive portfolio of applications, platform and infrastructure technologies is designed to address an organization’s IT environment needs including business process, infrastructure and development requirements.

Oracle’s is an extremely profitable “razor and blades” business model. In addition to 70% (and growing over time) of its earnings coming from the recurring revenue businesses of software support, hardware support and cloud software, Oracle’s massive size gives it a large competitive advantage with respect to staying at the forefront of technology. As an example of this will be the company shortly releasing the world’s first fully autonomous database. We believe that Oracle’s artificial intelligence and machine learning business is poised to have a significant impact in the enterprise market.

If there’s one thing that strikes us whenever we hear Chairman Larry Ellison and co-CEOs Mark Hurd and Safra Catz speak on earnings calls and at Financial Analyst Meetings, it’s their passion for Oracle and their desire to win. Oracle has one of the most experienced and highly incentivized management teams in the industry.

One of the reasons why Oracle continues to remain attractively valued is because it was considered to be relatively late to transitioning to the cloud. Oracle’s cloud transition model is starting to work as evidenced by growth in cloud subscriptions now more than offsetting the license revenue declines, even organically, marking it a key milestone. If Oracle is successful in defending its large installed base of customers and migrating them to the cloud, this could result in meaningful upside to revenues and earnings. The stock continues to trade at an attractive free cash flow yield of 6.7%.

About Us

PORTFOLIO CHARACTERISTICS

Average market cap A$189.3bn

WAVG⁴ forecast dividend yield 1.50%

Wt AVG forecast PE ratio 20.3x

WAVG ROE 21.0%

Current FX hedging position 0% overseas exposure hedged back into $A

Current put protection 50%

Benchmark Unconstrained

KEY INFORMATION

APIR code SLT0041AU

ASX mFund code INS01

Distributions paid Annually, as at 30 June

Unit pricing Daily

Minimum initial investment $10,000

Applications & redemptions Each Sydney business day

Entry & exit fee Nil

Buy/Sell spread 0.20%/0.20%

MER 1.3% (plus GST) p.a.

Investment style

Concentrated, large cap global equity fund, incorporating active currency management and downside protection strategies

Investment objectives

To provide long term capital growth and some income through investment in listed global securities. Insync believes that a strong focus on capital preservation will lead to superior relative and absolute returns over time

How to apply

Apply online here.

#MonthlyFundCommentary

  • LinkedIn Social Icon
  • YouTube Social  Icon

©2018 by Insync Funds Management Pty Ltd.

Disclaimer

The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.